SoftBank has led the series E round through its Vision Fund 2, doubling Formlabs’ valuation to $2bn in the process.

US-based 3D printing technology developer Formlabs received $150m in a series E round yesterday led by telecommunications conglomerate SoftBank’s Vision Fund 2.

The round valued Formlabs at $2bn, doubling its previous valuation.

Formlabs produces 3D printers, materials and software for sectors such as healthcare, where they have been used to manufacture tens of millions of nasopharyngeal swabs for covid tests.

The company launched out of interdisciplinary research laboratory MIT Media Lab and its Center for Bits and Atoms in 2011.

Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.